Actionable Options for Monday March 31

Actionable Options for Monday March 31

Options having increasing call volume and implied volatility: COP ZNGA CBRL

Options having increasing put volume and implied volatility: RAD MNKD WLT TCK

Teva (TEVA) is recently up $3.06 to $52.52 after the Supreme Court agreed to hear an appeal by Teva of a court ruling that would enable generic versions of its multiple sclerosis drug, Copaxone, to be sold in May. April option implied volatility is at 26, May is at 27, June is at 29, September is at 26; compared to its 26-week average of 27.

AT&T (T) is recently up 12c to $35.19 after the company's board of directors authorized the repurchase of up to 300M shares, or about 6% of its common shares outstanding. The company also noted it has 125M shares left under its buyback authorization that was issued in March of last year. April option implied volatility is at 14, May is at 15, July is at 14; compared to its 26-week average of 16.

Biogen Idec (BIIB) is recently up $10.62 to $304.74 after announcing that the U.S. FDA has approved Alprolix, the first recombinant, DNA derived hemophilia B therapy with prolonged circulation in the body. April option implied volatility is at 37, May is at 41, July is at 37; compared to its 26-week average of 37.